The AI Reading Prostate Biopsies Now Works in Over 200 Hospitals Without Recalibration
Paige Prostate, the first AI-based pathology product ever cleared by the FDA, is being highlighted as a fully autonomous system that improves prostate cancer detection and has now been validated across more than 200 institutions without site-specific recalibration. Pathologists say it's a powerful assistive tool, but caution it isn't a replacement for human review.